Ticker Launch
Sign inTry it free

SPAC · Merger completed

Larkspur Health Acquisition Corp.

Business combination with Old ZyVersa

Larkspur Health Acquisition Corp. is a blank-check company (SPAC) that raised $75M in its initial public offering on Dec 22, 2021, listing on Nasdaq Global Market. It completed its business combination with Old ZyVersa on Dec 12, 2022; the combined company is ZyVersa Therapeutics, Inc. (ZVSA). McDermott Will & Emery advised the SPAC and Manatt, Phelps & Phillips advised the underwriters on the IPO.

Old ZyVersa was a drug-development company whose pipeline included VAR 200, already in clinical evaluation, and IC 100, which it planned to advance into the clinic, ahead of its combination with the SPAC Larkspur.

Status
Merger completed
IPO date
Dec 22, 2021
IPO size
$75M
IPO exchange
Nasdaq Global Market
Target
Old ZyVersa (ZyVersa Therapeutics, Inc., a Florida corporation)
Announced
Jul 22, 2022
Closed
Dec 12, 2022
Combined company
ZyVersa Therapeutics, Inc. (ZVSA)
SPAC counsel (IPO)
McDermott Will & Emery
Underwriters' counsel (IPO)
Manatt, Phelps & Phillips

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022